Literature DB >> 23223131

CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22.

Dirkjan Hijnen1, Edward F Knol, Yoony Y Gent, Barbara Giovannone, Scott J P Beijn, Thomas S Kupper, Carla A F M Bruijnzeel-Koomen, Rachael A Clark.   

Abstract

Although CD4(+) T cells are known to contribute to the pathology of atopic dermatitis (AD) and psoriasis, the role of CD8(+) T cells in these diseases remains poorly characterized. The aim of this study was to characterize the cytokine production of T cells from AD and psoriasis skin. We found that CD4(+) T cells isolated from AD skin were largely Th2 (T helper type 2) biased, in agreement with prior reports. However, we also observed large numbers of CD8(+) T cells producing IL-13, IFN-γ, and IL-22. We observed increased numbers of CD8(+) T cells isolated from AD skin, and immunohistochemistry studies confirmed the presence of CD8(+) T cells in the dermis and epidermis of AD skin lesions. Surprisingly, T-cell cytokine production was similar in the lesional and nonlesional skin of patients with AD. T cells from psoriatic lesional skin predominantly produced IFN-γ, IL-17, and IL-22, in agreement with prior studies. However, in addition to Th17 cells, we observed high percentages of CD8(+) T cells that produced both IL-22 and IL-17 in psoriatic skin lesions. Our findings demonstrate that CD8(+) T cells are a significant and previously unappreciated source of inflammatory cytokine production in both AD and psoriasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223131      PMCID: PMC3835628          DOI: 10.1038/jid.2012.456

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  33 in total

1.  T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis.

Authors:  A Trautmann; M Akdis; D Kleemann; F Altznauer; H U Simon; T Graeve; M Noll; E B Bröcker; K Blaser; C A Akdis
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  Psoriasis.

Authors:  Frank O Nestle; Daniel H Kaplan; Jonathan Barker
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

3.  CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis.

Authors:  Ana Hennino; Catherine Jean-Decoster; Françoise Giordano-Labadie; Sabine Debeer; Béatrice Vanbervliet; Aurore Rozières; Anne-Marie Schmitt; Jean-François Nicolas
Journal:  J Allergy Clin Immunol       Date:  2011-01-13       Impact factor: 10.793

Review 4.  Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts.

Authors:  Emma Guttman-Yassky; Kristine E Nograles; James G Krueger
Journal:  J Allergy Clin Immunol       Date:  2011-03-21       Impact factor: 10.793

5.  Tight junction defects in patients with atopic dermatitis.

Authors:  Anna De Benedetto; Nicholas M Rafaels; Laura Y McGirt; Andrei I Ivanov; Steve N Georas; Chris Cheadle; Alan E Berger; Kunzhong Zhang; Sadasivan Vidyasagar; Takeshi Yoshida; Mark Boguniewicz; Tissa Hata; Lynda C Schneider; Jon M Hanifin; Richard L Gallo; Natalija Novak; Stephan Weidinger; Terri H Beaty; Donald Y M Leung; Kathleen C Barnes; Lisa A Beck
Journal:  J Allergy Clin Immunol       Date:  2010-12-15       Impact factor: 10.793

6.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

7.  Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities.

Authors:  Mayte Suárez-Fariñas; Suzanne J Tintle; Avner Shemer; Andrea Chiricozzi; Kristine Nograles; Irma Cardinale; Shenghui Duan; Anne M Bowcock; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2011-04       Impact factor: 10.793

8.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

Authors:  Stefanie Eyerich; Kilian Eyerich; Davide Pennino; Teresa Carbone; Francesca Nasorri; Sabatino Pallotta; Francesca Cianfarani; Teresa Odorisio; Claudia Traidl-Hoffmann; Heidrun Behrendt; Stephen R Durham; Carsten B Schmidt-Weber; Andrea Cavani
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

9.  Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes.

Authors:  Kazushige Midorikawa; Kazuhisa Ouhara; Hitoshi Komatsuzawa; Toshihisa Kawai; Sakuo Yamada; Tamaki Fujiwara; Kenshi Yamazaki; Koji Sayama; Martin A Taubman; Hidemi Kurihara; Koji Hashimoto; Motoyuki Sugai
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production.

Authors:  Dawn C Newcomb; Madison G Boswell; Weisong Zhou; Matthew M Huckabee; Kasia Goleniewska; Carla M Sevin; Gurjit K Khurana Hershey; Jay K Kolls; R Stokes Peebles
Journal:  J Allergy Clin Immunol       Date:  2011-01-13       Impact factor: 10.793

View more
  78 in total

1.  Different cytokine profiles of skin-derived T cell cultures from patients with atopic dermatitis and psoriasis.

Authors:  Britta C Martel; Beatrice Dyring-Andersen; Lone Skov; Kristian Thestrup-Pedersen; Søren Skov; Kresten Skak; Lars K Poulsen
Journal:  Inflamm Res       Date:  2015-12-31       Impact factor: 4.575

2.  Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases.

Authors:  Ellen H van den Bogaard; Geuranne S Tjabringa; Irma Joosten; Mieke Vonk-Bergers; Esther van Rijssen; Henk J Tijssen; Mirthe Erkens; Joost Schalkwijk; Hans J P M Koenen
Journal:  J Invest Dermatol       Date:  2013-10-11       Impact factor: 8.551

Review 3.  Cytokines in psoriasis.

Authors:  Jaymie Baliwag; Drew H Barnes; Andrew Johnston
Journal:  Cytokine       Date:  2015-01-10       Impact factor: 3.861

4.  Cytokine effects induced by the human autoallergen α-NAC.

Authors:  Susanne Hradetzky; Lennart M Roesner; Hari Balaji; Annice Heratizadeh; Irene Mittermann; Rudolf Valenta; Thomas Werfel
Journal:  J Invest Dermatol       Date:  2014-01-17       Impact factor: 8.551

5.  Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling.

Authors:  A Johnston; A M Guzman; W R Swindell; F Wang; S Kang; J E Gudjonsson
Journal:  Br J Dermatol       Date:  2014-06-24       Impact factor: 9.302

6.  Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis.

Authors:  Stanley Cheuk; Maria Wikén; Lennart Blomqvist; Susanne Nylén; Toomas Talme; Mona Ståhle; Liv Eidsmo
Journal:  J Immunol       Date:  2014-03-07       Impact factor: 5.422

7.  The humoral immunity to epidermal and dermal antigens in psoriasis: a downstream rather than an upstream event.

Authors:  Leena Chularojanamontri; Chanisada Wongpraparut; Narumol Silpa-Archa; Paleerath Peerapen; Wanida Boonmark; Kanokvalai Kulthanan; Visith Thongboonkerd
Journal:  Clin Exp Med       Date:  2018-05-10       Impact factor: 3.984

8.  IL-17 producing innate lymphoid cells 3 (ILC3) but not Th17 cells might be the potential danger factor for preeclampsia and other pregnancy associated diseases.

Authors:  Prince A Barnie; Xin Lin; Yueqin Liu; Huaxi Xu; Zhaoliang Su
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 9.  Psoriasis.

Authors:  Paola Di Meglio; Federica Villanova; Frank O Nestle
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

10.  Cutting Edge: Skin CCR10+ CD8+ T Cells Support Resident Regulatory T Cells through the B7.2/Receptor Axis To Regulate Local Immune Homeostasis and Response.

Authors:  Yaoyao Fu; Jie Yang; Na Xiong
Journal:  J Immunol       Date:  2016-05-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.